(1S,4S)-2-Boc-2,5-diazabicyclo[2.2.1]heptane → HCID 66747727, compound
Reaction equation
[C@H:1]12[CH2:7][C@H:4]([NH:5][CH2:6]1)[CH2:3][N:2]2[C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9].Cl[C:16]1[CH:21]=[C:20]([O:22][CH2:23][CH:24]([CH3:26])[CH3:25])[N:19]=[CH:18][N:17]=1>>[CH2:23]([O:22][C:20]1[N:19]=[CH:18][N:17]=[C:16]([N:5]2[CH2:6][C@@H:1]3[CH2:7][C@H:4]2[CH2:3][N:2]3[C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[CH:21]=1)[CH:24]([CH3:26])[CH3:25]Participants
3
Procedure
The title compound was prepared according to the procedure described in Step-1 of Intermediate C using tert-butyl (1S,4S)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate and 4-chloro-6-isobutoxypyrimidine.
Sources & evidence
- ORD record
- ord-090c5163a28c469dbd945af8ce313503
- Source dataset
- uspto-grants-2015_04
- Patent number
- US08999974B2
Reaction notes
Loading…